Back to Search Start Over

Cell-specific bioorthogonal tagging of glycoproteins.

Authors :
Cioce A
Calle B
Rizou T
Lowery SC
Bridgeman VL
Mahoney KE
Marchesi A
Bineva-Todd G
Flynn H
Li Z
Tastan OY
Roustan C
Soro-Barrio P
Rafiee MR
Garza-Garcia A
Antonopoulos A
Wood TM
Keenan T
Both P
Huang K
Parmeggian F
Snijders AP
Skehel M
Kjær S
Fascione MA
Bertozzi CR
Haslam SM
Flitsch SL
Malaker SA
Malanchi I
Schumann B
Source :
Nature communications [Nat Commun] 2022 Oct 25; Vol. 13 (1), pp. 6237. Date of Electronic Publication: 2022 Oct 25.
Publication Year :
2022

Abstract

Altered glycoprotein expression is an undisputed corollary of cancer development. Understanding these alterations is paramount but hampered by limitations underlying cellular model systems. For instance, the intricate interactions between tumour and host cannot be adequately recapitulated in monoculture of tumour-derived cell lines. More complex co-culture models usually rely on sorting procedures for proteome analyses and rarely capture the details of protein glycosylation. Here, we report a strategy termed Bio-Orthogonal Cell line-specific Tagging of Glycoproteins (BOCTAG). Cells are equipped by transfection with an artificial biosynthetic pathway that transforms bioorthogonally tagged sugars into the corresponding nucleotide-sugars. Only transfected cells incorporate bioorthogonal tags into glycoproteins in the presence of non-transfected cells. We employ BOCTAG as an imaging technique and to annotate cell-specific glycosylation sites in mass spectrometry-glycoproteomics. We demonstrate application in co-culture and mouse models, allowing for profiling of the glycoproteome as an important modulator of cellular function.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
13
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
36284108
Full Text :
https://doi.org/10.1038/s41467-022-33854-0